Albert Liu, MD

Assistant Professor

Dr. Liu is a cardiac electrophysiologist with expertise in treating heart rhythm disorders. He performs catheter ablations to treat supra-ventricular and ventricular arrhythmias, and also specializes in lead management and implantation of pacemakers and defibrillators. He has additional interests in quality improvement and the use of the electronic medical record, as well as further elucidating causes of sudden cardiac death.

Education
06/2025 - Clinical Cardiac Electrophysiology Fellowship, University of California, San Francisco
6/2023 - Cardiovascular Disease Fellowship, Northwestern University
06/2019 - Internal Medicine Residency, University of California, San Francisco
MD, 06/2016 - Medicine, University of California, Los Angeles
BA, 06/2012 - Chemistry, Pomona College
Publications

  1. McMahan VM, Pope E, Luna Marti X, Liu AY, Coffin PO. Provider Perspectives on the Delivery of Long-Acting PrEP for HIV Prevention to Men Who Have Sex with Men and Who Use Methamphetamine. AIDS patient care and STDs 2026. PMID: 42552859


  2. Anderson PL, Pang AP, Coyle RP, Schlachetzki J, Molina AJA, Bushman L, Aguado J, Hill B, Liu AY, Brooks KM, Erlandson KM, Corley MJ. An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics. medRxiv : the preprint server for health sciences 2026. PMID: 41929344


  3. McMahan VM, Moreno C, Al-Tayyib A, Ma Y, McFarland W, Sey EK, Wilson EC, Liu AY, Coffin PO, Glick SN. Interest in Long-Acting PrEP by Methamphetamine Use Among Men Who Have Sex with Men in Four Western US Cities. AIDS and behavior 2026. PMID: 41678009


  4. Wong CX, Kataoka S, Xiong N, Liu A, Morin D, Pundi K, Valappil SP, Ariyaratnam JP, Kheiri B, Sheikh AH, Tseng Z, Nogami A, Scheinman M. Focus on the Fascicles: A Collection of Challenging Cases. JACC. Clinical electrophysiology 2026. PMID: 41575413


  5. Liu AY, Pellegrini CN. Compression Therapy for Vasovagal Syncope: There May Still Be Hope. Journal of the American College of Cardiology 2025. PMID: 40769670


  6. Liu A, Marcus GM. What Is a Pacemaker? JAMA 2025. PMID: 40471556


  7. Wilson EC, Myers J, Muñoz Acosta G, Sicro S, Schaeffer E, Alleyne CD, Diaz A, Walker N, Vinson J, Buchbinder S, Scott H, Liu A. Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San Francisco. AIDS patient care and STDs 2025. PMID: 40474770


  8. Liu AY, Torres TS, Alleyne CD, Vinson J, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Muessig KE, Buchbinder SP, Sullivan P, Hightow-Weidman LB, Scott H. Developing a Novel Mobile App to Support HIV Testing and Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Formative and Technical Pilot Study. JMIR human factors 2025. PMID: 40440084


  9. Buchbinder SP, Liu AY. CROI 2025: global epidemiology and prevention of HIV and other sexually transmitted diseases. Topics in antiviral medicine 2025. PMID: 40472386


  11. Mantell JE, Bauman LJ, Bonett S, Buchbinder S, Hoffman S, Storholm ED, McCoy K, Rael CT, Cowan E, Gonzalez-Argoti T, Safa H, Scott H, Murtaugh KL, Wilson NL, Liu A. Innovation in Providing Equitable Pre-exposure Prophylaxis Services in the United States: Expanding Access in Nontraditional Settings. Journal of acquired immune deficiency syndromes (1999) 2025. PMID: 40163068


  12. Rodriguez-Diaz CE, Jaramillo J, Santiago-Rivera Y, Harkness A, Cantos VD, Liu A, Buchbinder S, Saldana CS, Gonzalez K, Malavé-Rivera SM, Reyes N, Vinson J, Scott JY, Lanzi RG, Hidalgo B. Language Justice in Implementation Science: Experiences Working With Latinxs to End the HIV Epidemic. Journal of acquired immune deficiency syndromes (1999) 2025. PMID: 40163061


  13. McCoy K, Mantell JE, Deiss R, Liu A, Bauman LJ, Bonner CP, Vinson J, Buchbinder S. Pre-Exposure Prophylaxis Awareness and Demand Creation: Overlooked Populations and Opportunities to Move Forward. Journal of acquired immune deficiency syndromes (1999) 2025. PMID: 40163069


  14. Biello KB, Mayer KH, Scott H, Valente PK, Hill-Rorie J, Buchbinder S, Ackah-Toffey L, Sullivan PS, Hightow-Weidman L, Liu AY. The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial. JMIR public health and surveillance 2025. PMID: 39908084


  15. Liu AY, Marcus GM, Lee BK, Moss JD, Pellegrini CN. Loss of right ventricular capture: When it is not the lead's fault. HeartRhythm case reports 2025. PMID: 40330685


  16. Velloza J, Liu AY, Katz AWK, van der Straten A, Siegler AJ, Scott H, Wilde G, Lockard A, Christie RH, Buchbinder SP. Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration. AIDS care 2024. PMID: 39222964


  17. Enns B, Sui Y, Guerra-Alejos BC, Humphrey L, Piske M, Zang X, Doblecki-Lewis S, Feaster DJ, Frye VA, Geng EH, Liu AY, Marshall BDL, Rhodes SD, Sullivan PS, Nosyk B, localized economic modelling study group. Estimating the potential value of MSM-focused evidence-based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model-based analysis. Journal of the International AIDS Society 2024. PMID: 38965982


  18. Gaddam M, Liu A, Lohrmann G, Breed A, Passman R. KardiaMobile 6L versus 12-lead ECG: Effects on clinic utilization time. Journal of cardiovascular electrophysiology 2024. PMID: 38894503


  19. Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H, COVID-19 Prevention Network (CoVPN). SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA network open 2024. PMID: 38780941


  21. Liu AY, Charron J, Fugaro D, Spoolstra S, Kaplan R, Lohrmann G, Gao X, Gay H, Passman R, Kim S, Lin AC, Chicos A, Arora R, Patil K, Pfenniger A, Knight BP, Verma N. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. Journal of cardiovascular electrophysiology 2023. PMID: 36640424


  22. Mitchell KM, Boily MC, Hanscom B, Moore M, Todd J, Paz-Bailey G, Wejnert C, Liu A, Donnell DJ, Grinsztejn B, Landovitz RJ, Dimitrov DT. Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083. Lancet regional health. Americas 2023. PMID: 36844011


  23. Lohrmann G, Liu A, Ziegler P, Monteiro J, Varberg N, Passman R. CHA2DS2VASc score as a predictor of ablation success defined by continuous long-term monitoring. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2022. PMID: 35917047


  24. Liu A, Feinstein M. Addressing gaps in cardiovascular care for people with HIV: bridging scientific evidence and practice. Current opinion in HIV and AIDS 2022. PMID: 35938461


  25. Mayer KH, Yuhas K, Amico KR, Wilkin T, Landovitz RJ, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Cottle LM, Marcus C, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu AY, Frank I, Ho K, Santana J, Stekler JD, Chen YQ, McCauley M, Gulick RM, HPTN 069/ACTG 5305 Study Team. Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). AIDS and behavior 2022. PMID: 35687192


  26. Roberts ST, Hawley I, Luecke E, Mensch B, Wagner T, Hoesley C, McClure T, Dominguez Islas CP, Piper JM, Liu AY, van der Straten A. Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial. Journal of women's health (2002) 2021. PMID: 34665672


  27. Liu AY, Dominguez Islas C, Gundacker H, Neradilek B, Hoesley C, van der Straten A, Hendrix CW, Beamer M, Jacobson CE, McClure T, Harrell T, Bunge K, Devlin B, Nuttall J, Spence P, Steytler J, Piper JM, Marzinke MA, MTN-036/IPM 047 Protocol Team for the Microbicide Trials Network. Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. Journal of the International AIDS Society 2021. PMID: 34118115


  28. Seneviratne HK, Hamlin AN, Li S, Grinsztejn B, Dawood H, Liu AY, Kuo I, Hosseinipour MC, Panchia R, Cottle L, Chau G, Adeyeye A, Rinehart AR, McCauley M, Eron JS, Cohen MS, Landovitz RJ, Hendrix CW, Bumpus NN. Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study. ACS pharmacology & translational science 2021. PMID: 33615175


  29. Liu AY, Laborde ND, Coleman K, Vittinghoff E, Gonzalez R, Wilde G, Thorne AL, Ikeguchi E, Shafner L, Sunshine L, van der Straten A, Siegler AJ, Buchbinder S. DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men. AIDS and behavior 2020. PMID: 33044687


  30. Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. The importance of PrEP persistence in preventing HIV infections on PrEP. Journal of the International AIDS Society 2020. PMID: 32844591


  31. Tang EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, Bacon O, Chege W, Coleman ME, Elion R, Buchbinder S, Kolber MA, Liu AY, Cohen SE. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis. AIDS (London, England) 2020. PMID: 32205724


  32. Landovitz RJ, Li S, Eron JJ, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Eshleman SH, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Cohen MS, McCauley M, Hendrix CW. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. The lancet. HIV 2020. PMID: 32497491


  33. Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States. Journal of the International AIDS Society 2020. PMID: 32294338


  34. Liu AY, O'Riordan DL, Marks AK, Bischoff KE, Pantilat SZ. A Comparison of Hospitalized Patients With Heart Failure and Cancer Referred to Palliative Care. JAMA network open 2020. PMID: 32101304


  35. Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Magnus M, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS. Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. PMID: 31125395


  36. Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY. Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. Journal of acquired immune deficiency syndromes (1999) 2019. PMID: 31095005


  37. Liu AY, Vittinghoff E, von Felten P, Rivet Amico K, Anderson PL, Lester R, Andrew E, Estes I, Serrano P, Brothers J, Buchbinder S, Hosek S, Fuchs JD. Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. PMID: 30239620


  38. Hamon D, Swid MA, Rajendran PS, Liu A, Boyle NG, Shivkumar K, Bradfield JS. Premature ventricular contraction diurnal profiles predict distinct clinical characteristics and beta-blocker responses. Journal of cardiovascular electrophysiology 2019. PMID: 30964570


  39. Jenness SM, Maloney KM, Smith DK, Hoover KW, Goodreau SM, Rosenberg ES, Weiss KM, Liu AY, Rao DW, Sullivan PS. Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States. American journal of epidemiology 2019. PMID: 30312365


  40. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, Gandhi M, Buchbinder SP. Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network. Open forum infectious diseases 2019. PMID: 30949540


  41. Siegler AJ, Mayer KH, Liu AY, Patel RR, Ahlschlager LM, Kraft CS, Fish R, Wiatrek SE, Sullivan PS. Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. PMID: 29982304


  42. Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS medicine 2018. PMID: 30408115


  43. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Gandhi M, Buchbinder SP. Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System. Journal of acquired immune deficiency syndromes (1999) 2018. PMID: 30085955


  44. Doblecki-Lewis S, Liu AY, Feaster DJ, Cohen SE, Elion R, Bacon O, Coleman M, Cardenas G, Kolber MA. Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project. Journal of acquired immune deficiency syndromes (1999) 2018. PMID: 29771790


  45. Liu A, Curfman G. The Trade-offs When Focusing on the Mortality Benefit. JAMA internal medicine 2018. PMID: 29482199


  46. Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, Kouyate A, Gilmore HJ, Buchbinder SP, Lester RT, Grant RM, Liu AY. A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis. AIDS patient care and STDs 2018. PMID: 29565183


  47. Tang EC, Vittinghoff E, Anderson PL, Cohen SE, Doblecki-Lewis S, Bacon O, Coleman ME, Buchbinder SP, Chege W, Kolber MA, Elion R, Shlipak M, Liu AY. Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project. Journal of acquired immune deficiency syndromes (1999) 2018. PMID: 28991887


  48. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018. PMID: 29020194


  49. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS medicine 2017. PMID: 29112956


  50. Hamon D, Abehsira G, Gu K, Liu A, Blaye-Felice Sadron M, Billet S, Kambur T, Swid MA, Boyle NG, Dandamudi G, Maury P, Chen M, Miller JM, Lellouche N, Shivkumar K, Bradfield JS. Circadian variability patterns predict and guide premature ventricular contraction ablation procedural inducibility and outcomes. Heart rhythm 2017. PMID: 28765087


  51. Psotka MA, McKee KY, Liu AY, Elia G, De Marco T. Palliative Care in Heart Failure: What Triggers Specialist Consultation? Progress in cardiovascular diseases 2017. PMID: 28483606


  52. Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, Gandhi M. Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS research and human retroviruses 2017. PMID: 28253024


  53. Cranston RD, Lama JR, Richardson BA, Carballo-Diéguez A, Kunjara Na Ayudhya RP, Liu K, Patterson KB, Leu CS, Galaska B, Jacobson CE, Parikh UM, Marzinke MA, Hendrix CW, Johnson S, Piper JM, Grossman C, Ho KS, Lucas J, Pickett J, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu AY, Mayer KH, Zorrilla C, Schwartz JL, Rooney J, McGowan I, MTN-017 Protocol Team. MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017. PMID: 27986684


  54. Grinsztejn B, Jalil EM, Monteiro L, Velasque L, Moreira RI, Garcia AC, Castro CV, Krüger A, Luz PM, Liu AY, McFarland W, Buchbinder S, Veloso VG, Wilson EC, Transcender Study Team. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. The lancet. HIV 2017. PMID: 28188030


  55. Solomon MM, Schechter M, Liu AY, McMahan VM, Guanira JV, Hance RJ, Chariyalertsak S, Mayer KH, Grant RM, iPrEx Study Team. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B. Journal of acquired immune deficiency syndromes (1999) 2016. PMID: 26413853


  56. Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, McMahan V, Mayer KH, David B, Schechter M, Grinsztejn B, Guanira J, Grant RM. Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016. PMID: 26797207


  57. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Liegler T, Rawlings MK, Trainor N, Blue RW, Estrada Y, Coleman ME, Cardenas G, Feaster DJ, Grant R, Philip SS, Elion R, Buchbinder S, Kolber MA. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA internal medicine 2016. PMID: 26571482


  58. Solomon MM, Mayer KH, Glidden DV, Liu AY, McMahan VM, Guanira JV, Chariyalertsak S, Fernandez T, Grant RM, iPrEx Study Team. Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014. PMID: 24928295


  59. Solomon MM, Lama JR, Glidden DV, Mulligan K, McMahan V, Liu AY, Guanira JV, Veloso VG, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Burns DN, Grant RM, iPrEx Study Team. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS (London, England) 2014. PMID: 24499951


  60. Marcus JL, Glidden DV, McMahan V, Lama JR, Mayer KH, Liu AY, Montoya-Herrera O, Casapia M, Hoagland B, Grant RM. Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men. PloS one 2014. PMID: 24637511


  61. Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, Goicochea P, Grant RM. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. The Lancet. Infectious diseases 2014. PMID: 24613084


  62. Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, McMahan V, Kallas EG, Montoya-Herrera O, Pilotto J, Grant RM. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PloS one 2013. PMID: 24367497


  64. Liu AY, Grant RM, Buchbinder SP. Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA 2006. PMID: 16905792